![Levofloxacin Dosing Regimen in Severely Morbidly Obese Patients (BMI ≥40 kg/m2) Should Be Guided by Creatinine Clearance Estimates Based on Ideal Body Weight and Optimized by Therapeutic Drug Monitoring | SpringerLink Levofloxacin Dosing Regimen in Severely Morbidly Obese Patients (BMI ≥40 kg/m2) Should Be Guided by Creatinine Clearance Estimates Based on Ideal Body Weight and Optimized by Therapeutic Drug Monitoring | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40262-014-0154-1/MediaObjects/40262_2014_154_Fig2_HTML.gif)
Levofloxacin Dosing Regimen in Severely Morbidly Obese Patients (BMI ≥40 kg/m2) Should Be Guided by Creatinine Clearance Estimates Based on Ideal Body Weight and Optimized by Therapeutic Drug Monitoring | SpringerLink
![Intensified treatment with high dose Rifampicin and Levofloxacin compared to standard treatment for adult patients with Tuberculous Meningitis (TBM-IT): protocol for a randomized controlled trial – topic of research paper in Clinical Intensified treatment with high dose Rifampicin and Levofloxacin compared to standard treatment for adult patients with Tuberculous Meningitis (TBM-IT): protocol for a randomized controlled trial – topic of research paper in Clinical](https://cyberleninka.org/viewer_images/237462/f/1.png)
Intensified treatment with high dose Rifampicin and Levofloxacin compared to standard treatment for adult patients with Tuberculous Meningitis (TBM-IT): protocol for a randomized controlled trial – topic of research paper in Clinical
LEVAQUIN (levofloxacin) TABLETS LEVAQUIN (levofloxacin) ORAL SOLUTION LEVAQUIN (levofloxacin) INJECTION LEVAQUIN (levofloxacin i
![Microorganisms | Free Full-Text | Optimizing Antimicrobial Drug Dosing in Critically Ill Patients | HTML Microorganisms | Free Full-Text | Optimizing Antimicrobial Drug Dosing in Critically Ill Patients | HTML](https://www.mdpi.com/microorganisms/microorganisms-09-01401/article_deploy/html/images/microorganisms-09-01401-g001.png)
Microorganisms | Free Full-Text | Optimizing Antimicrobial Drug Dosing in Critically Ill Patients | HTML
![Pharmacokinetics and Safety of WHO-Recommended Dosage and Higher Dosage of Levofloxacin for Tuberculosis Treatment in Children: a Pilot Study - International Journal of Infectious Diseases Pharmacokinetics and Safety of WHO-Recommended Dosage and Higher Dosage of Levofloxacin for Tuberculosis Treatment in Children: a Pilot Study - International Journal of Infectious Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/ec04a9ed-1340-4507-944a-4e83d3fb2947/gr1_lrg.jpg)
Pharmacokinetics and Safety of WHO-Recommended Dosage and Higher Dosage of Levofloxacin for Tuberculosis Treatment in Children: a Pilot Study - International Journal of Infectious Diseases
![Levofloxacin Dosing Regimen in Severely Morbidly Obese Patients (BMI ≥40 kg/m2) Should Be Guided by Creatinine Clearance Estimates Based on Ideal Body Weight and Optimized by Therapeutic Drug Monitoring | SpringerLink Levofloxacin Dosing Regimen in Severely Morbidly Obese Patients (BMI ≥40 kg/m2) Should Be Guided by Creatinine Clearance Estimates Based on Ideal Body Weight and Optimized by Therapeutic Drug Monitoring | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40262-014-0154-1/MediaObjects/40262_2014_154_Fig1_HTML.gif)
Levofloxacin Dosing Regimen in Severely Morbidly Obese Patients (BMI ≥40 kg/m2) Should Be Guided by Creatinine Clearance Estimates Based on Ideal Body Weight and Optimized by Therapeutic Drug Monitoring | SpringerLink
![PDF) Pharmacokinetics and pharmacodynamics of levofloxacin injection in healthy Chinese volunteers and dosing regimen optimization PDF) Pharmacokinetics and pharmacodynamics of levofloxacin injection in healthy Chinese volunteers and dosing regimen optimization](https://i1.rgstatic.net/publication/236906311_Pharmacokinetics_and_pharmacodynamics_of_levofloxacin_injection_in_healthy_Chinese_volunteers_and_dosing_regimen_optimization/links/564e859308ae1ef9296ca11f/largepreview.png)
PDF) Pharmacokinetics and pharmacodynamics of levofloxacin injection in healthy Chinese volunteers and dosing regimen optimization
![Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial - The Lancet Oncology Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial - The Lancet Oncology](https://www.thelancet.com/cms/attachment/7ed4a9a4-1bf5-4179-a438-98f1cc37bd0b/gr1_lrg.jpg)